NDC 70518-4359-04 - HYDROCHLOROTHIAZIDE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70518-4359
- Requested NDC
- 70518-4359-04
- Package NDCs from labels
- 70518-4359-0, 70518-4359-1, 70518-4359-2, 70518-4359-3, 70518-4359-4, 70518-4359-04
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2026-10-12
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| HYDROCHLOROTHIAZIDE TABLETS, USP Rx only | REMEDYREPACK INC. | 2026-10-12 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70518-4359-0 | HYDROCHLOROTHIAZIDE | 15 in 1 BOTTLE, PLASTIC | TABLET | 15 | 3 | |
| 70518-4359-1 | HYDROCHLOROTHIAZIDE | 30 in 1 BLISTER PACK | TABLET | 30 | 3 | |
| 70518-4359-2 | HYDROCHLOROTHIAZIDE | 90 in 1 BOTTLE, PLASTIC | TABLET | 90 | 3 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Preferred Pharmaceuticals Inc. | 5fc69fbf-c2d2-41ef-99bb-62a76ef74db2 | 2026-10-19 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Telmisartan and Hydrochlorothiazide | TELMISARTAN AND HYDROCHLOROTHIAZIDE | Aurobindo Pharma Limited | 681dfb5c-fc5c-427e-81f6-4b4e934978a2 | 2026-10-16 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | REMEDYREPACK INC. | 3bea11a3-eb07-46b2-9b91-f8a48a2f3b7e | 2026-10-12 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 31a3d1cb-0f52-4818-965d-7584374bb23e | 2026-10-12 | Warnings, Adverse reactions | ANDA085182 70518-4359-0 70518-4359-2 70518-4359-3 70518-4359-1 70518-4359-4 70518-4359 70518435904 310798 5da40fa3-974e-ccd0-e063-6294a90a36ce 31a3d1cb-0f52-4818-965d-7584374bb23e 0J48LPH2TH |
| LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Granules Pharmaceuticals Inc. | b4168479-09ec-402c-89cc-456bc8485017 | 2026-10-08 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Advagen Pharma Ltd | f4b10352-a923-4713-9d33-8f3636941b2e | 2026-10-08 | Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | NuCare Pharmaceuticals,Inc. | 8bc8d5e2-a974-64ed-e053-2a95a90a8340 | 2026-10-08 | Warnings, Adverse reactions | 310798 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | St. Mary's Medical Park Pharmacy | 00b266d9-ac4a-e931-e063-6294a90a6a0b | 2026-10-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Westminster Pharmaceuticals, LLC | 0fc94bc2-fa38-439a-a609-1b4130cdacb1 | 2026-09-29 | Warnings, Adverse reactions | 0J48LPH2TH |
| OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | Ascend Laboratories, LLC | 798fee33-51ad-45d0-82f3-09289304139f | 2026-09-24 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Preferred Pharmaceuticals Inc. | b9b85048-5776-455f-bea6-6ab818cb8144 | 2026-09-24 | Warnings, Adverse reactions | 0J48LPH2TH |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 2dd7c2a4-d335-4c6f-b1e6-b0ae6eebab84 | 2026-09-23 | Warnings, Adverse reactions | 429503 0J48LPH2TH |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Zydus Lifesciences Limited | e92f1118-8eaf-4fa8-b167-1447550af1ab | 2026-09-18 | Boxed warning, Adverse reactions | 0J48LPH2TH |
| Bisoprolol Fumarate and Hydrochlorothiazide | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | Aurobindo Pharma Limited | 2db1a899-f115-4da5-89fe-6e5b41086f6c | 2026-09-18 | Warnings, Adverse reactions | 0J48LPH2TH |
| VALSARTAN AND HYDROCHLOROTHIAZIDE | VALSARTAN AND HYDROCHLOROTHIAZIDE | Golden State Medical Supply, Inc. | 5ba10848-9a4c-1a28-e063-6394a90ab047 | 2026-09-16 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | Aphena Pharma Solutions - Tennessee, LLC | 5ba2325f-5fc1-f6f0-e063-6294a90aefc6 | 2026-09-16 | Warnings, Adverse reactions | 429503 0J48LPH2TH |
| Metoprolol Tartrate and Hydrochlorothiazide | METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE | Mylan Pharmaceuticals Inc. | b6cf0f43-8dc3-4535-b651-daf1f9e0336c | 2026-09-15 | Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | REMEDYREPACK INC. | d383e0e5-4e00-44cc-9d6f-86e76f4e79e3 | 2026-09-15 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 206cd386-cf38-4e0f-80ec-685aea41b048 | 2026-09-15 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 1fad059f-f030-4dd8-b02a-bf3e775d37d2 | 2026-09-15 | Warnings, Adverse reactions | ANDA085182 197770 0J48LPH2TH |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.